<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Rhythm Biosciences Limited — News on 6ix</title>
<link>https://6ix.com/company/rhythm-biosciences-ltd</link>
<description>Latest news and press releases for Rhythm Biosciences Limited on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 14 Apr 2026 11:14:04 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/rhythm-biosciences-ltd" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683667ff78dffbe2df15e8d9.webp</url>
<title>Rhythm Biosciences Limited</title>
<link>https://6ix.com/company/rhythm-biosciences-ltd</link>
</image>
<item>
<title>Response to ASX Query Letter</title>
<link>https://6ix.com/company/rhythm-biosciences-ltd/news/response-to-asx-query-letter-146</link>
<guid isPermaLink="true">https://6ix.com/company/rhythm-biosciences-ltd/news/response-to-asx-query-letter-146</guid>
<pubDate>Tue, 14 Apr 2026 11:14:04 GMT</pubDate>
<description>Response to ASX Query Letter</description>
</item>
<item>
<title>First ColoSTAT Clinical Test Sale</title>
<link>https://6ix.com/company/rhythm-biosciences-ltd/news/first-colostat-clinical-test-sale</link>
<guid isPermaLink="true">https://6ix.com/company/rhythm-biosciences-ltd/news/first-colostat-clinical-test-sale</guid>
<pubDate>Wed, 11 Mar 2026 01:49:05 GMT</pubDate>
<description>First ColoSTAT Clinical Test Sale</description>
</item>
<item>
<title>NATA Accredits ColoSTAT Clinical Testing Service</title>
<link>https://6ix.com/company/rhythm-biosciences-ltd/news/nata-accredits-colostat-clinical-testing-service</link>
<guid isPermaLink="true">https://6ix.com/company/rhythm-biosciences-ltd/news/nata-accredits-colostat-clinical-testing-service</guid>
<pubDate>Mon, 09 Mar 2026 02:31:04 GMT</pubDate>
<description>NATA Accredits ColoSTAT Clinical Testing Service</description>
</item>
<item>
<title>RHY Executes SE Asian Genetype Distribution Agreement</title>
<link>https://6ix.com/company/rhythm-biosciences-ltd/news/rhy-executes-se-asian-genetype-distribution-agreement</link>
<guid isPermaLink="true">https://6ix.com/company/rhythm-biosciences-ltd/news/rhy-executes-se-asian-genetype-distribution-agreement</guid>
<pubDate>Wed, 04 Mar 2026 03:18:13 GMT</pubDate>
<description>RHY Executes SE Asian Genetype Distribution Agreement</description>
</item>
<item>
<title>Exercise of RHYO Options underwritten for $4.5m to $6.0m</title>
<link>https://6ix.com/company/rhythm-biosciences-ltd/news/exercise-of-rhyo-options-underwritten-for-dollar45m-to-dollar60m</link>
<guid isPermaLink="true">https://6ix.com/company/rhythm-biosciences-ltd/news/exercise-of-rhyo-options-underwritten-for-dollar45m-to-dollar60m</guid>
<pubDate>Wed, 25 Feb 2026 03:04:26 GMT</pubDate>
<description>Exercise of RHYO Options underwritten for $4.5m to $6.0m</description>
</item>
<item>
<title>Trading Halt</title>
<link>https://6ix.com/company/rhythm-biosciences-ltd/news/trading-halt-866</link>
<guid isPermaLink="true">https://6ix.com/company/rhythm-biosciences-ltd/news/trading-halt-866</guid>
<pubDate>Mon, 23 Feb 2026 04:05:12 GMT</pubDate>
<description>Trading Halt</description>
</item>
<item>
<title>Half-Year Financial Report and Appendix 4D</title>
<link>https://6ix.com/company/rhythm-biosciences-ltd/news/half-year-financial-report-and-appendix-4d-4</link>
<guid isPermaLink="true">https://6ix.com/company/rhythm-biosciences-ltd/news/half-year-financial-report-and-appendix-4d-4</guid>
<pubDate>Wed, 18 Feb 2026 08:35:09 GMT</pubDate>
<description>Half-Year Financial Report and Appendix 4D</description>
</item>
<item>
<title>Rhythm Bio enters ColoSTAT agreement with 4Cyte Pathology</title>
<link>https://6ix.com/company/rhythm-biosciences-ltd/news/rhythm-bio-enters-colostat-agreement-with-4cyte-pathology</link>
<guid isPermaLink="true">https://6ix.com/company/rhythm-biosciences-ltd/news/rhythm-bio-enters-colostat-agreement-with-4cyte-pathology</guid>
<pubDate>Tue, 17 Feb 2026 03:00:09 GMT</pubDate>
<description>Rhythm Bio enters ColoSTAT agreement with 4Cyte Pathology</description>
</item>
<item>
<title>ColoSTAT commercial deployment - First physician enrolled</title>
<link>https://6ix.com/company/rhythm-biosciences-ltd/news/colostat-commercial-deployment-first-physician-enrolled</link>
<guid isPermaLink="true">https://6ix.com/company/rhythm-biosciences-ltd/news/colostat-commercial-deployment-first-physician-enrolled</guid>
<pubDate>Wed, 11 Feb 2026 02:53:15 GMT</pubDate>
<description>ColoSTAT commercial deployment - First physician enrolled</description>
</item>
<item>
<title>Rhythm Biosciences Signs Manufacturing Agreement</title>
<link>https://6ix.com/company/rhythm-biosciences-ltd/news/rhythm-biosciences-signs-manufacturing-agreement</link>
<guid isPermaLink="true">https://6ix.com/company/rhythm-biosciences-ltd/news/rhythm-biosciences-signs-manufacturing-agreement</guid>
<pubDate>Tue, 03 Feb 2026 03:06:05 GMT</pubDate>
<description>Rhythm Biosciences Signs Manufacturing Agreement</description>
</item>
<item>
<title>Quarterly Activities Report and Appendix 4C</title>
<link>https://6ix.com/company/rhythm-biosciences-ltd/news/quarterly-activities-report-and-appendix-4c-30</link>
<guid isPermaLink="true">https://6ix.com/company/rhythm-biosciences-ltd/news/quarterly-activities-report-and-appendix-4c-30</guid>
<pubDate>Fri, 23 Jan 2026 03:54:16 GMT</pubDate>
<description>Quarterly Activities Report and Appendix 4C</description>
</item>
<item>
<title>Enhanced Genetype colorectal cancer risk test released - supports earlier disease detection and ColoSTAT® targeting</title>
<link>https://6ix.com/company/rhythm-biosciences-ltd/news/enhanced-genetype-colorectal-cancer-risk-test-released-supports-earlier-disease-detection-and-colostatr-targeting</link>
<guid isPermaLink="true">https://6ix.com/company/rhythm-biosciences-ltd/news/enhanced-genetype-colorectal-cancer-risk-test-released-supports-earlier-disease-detection-and-colostatr-targeting</guid>
<pubDate>Wed, 14 Jan 2026 03:40:00 GMT</pubDate>
<description>Rhythm Biosciences Ltd ('RHY', the 'Company' or the 'Group') (ASX: RHY), a transformative, predictive cancer diagnostics technology company is pleased to announce the commercial launch of its updated geneTypeTM Colorectal Cancer (CRC) Risk Assessment clinical test ("geneTypeTM CRC"), a significant advancement in personalised cancer risk prediction. The updated test incorporates additional clinical and lifestyle risk factors alongside the established 140-SNP polygenic risk score (PRS), delivering</description>
</item>
<item>
<title>datma and Rhythm Biosciences Announce Collaboration to Apply Federated Real-World Data to Genomic Diagnostic Development</title>
<link>https://6ix.com/company/rhythm-biosciences-ltd/news/datma-and-rhythm-biosciences-announce-collaboration-to-apply-federated-real-world-data-to-genomic-diagnostic-development</link>
<guid isPermaLink="true">https://6ix.com/company/rhythm-biosciences-ltd/news/datma-and-rhythm-biosciences-announce-collaboration-to-apply-federated-real-world-data-to-genomic-diagnostic-development</guid>
<pubDate>Mon, 22 Dec 2025 13:00:00 GMT</pubDate>
<description>datma, a leader in federated real-world data access, and Rhythm Biosciences Ltd (ASX:RHY), a leading developer in predictive cancer diagnostics technology including its geneType™ risk assessment portfolio, today announced an exploratory collaboration to evaluate how datma.FED, datma's federated data platform, could support and accelerate the commercialization of Rhythm's genomic-integrated cancer risk prediction portfolio.</description>
</item>
<item>
<title>Rhythm Initiates Commercialisation of ColoSTAT</title>
<link>https://6ix.com/company/rhythm-biosciences-ltd/news/rhythm-initiates-commercialisation-of-colostat</link>
<guid isPermaLink="true">https://6ix.com/company/rhythm-biosciences-ltd/news/rhythm-initiates-commercialisation-of-colostat</guid>
<pubDate>Fri, 12 Dec 2025 03:47:06 GMT</pubDate>
<description>Rhythm Initiates Commercialisation of ColoSTAT</description>
</item>
<item>
<title>Appendix 4C and Market Update</title>
<link>https://6ix.com/company/rhythm-biosciences-ltd/news/appendix-4c-and-market-update</link>
<guid isPermaLink="true">https://6ix.com/company/rhythm-biosciences-ltd/news/appendix-4c-and-market-update</guid>
<pubDate>Wed, 29 Oct 2025 02:23:18 GMT</pubDate>
<description>Appendix 4C and Market Update</description>
</item>
<item>
<title>Appendix 4E</title>
<link>https://6ix.com/company/rhythm-biosciences-ltd/news/appendix-4e-148</link>
<guid isPermaLink="true">https://6ix.com/company/rhythm-biosciences-ltd/news/appendix-4e-148</guid>
<pubDate>Fri, 29 Aug 2025 07:08:15 GMT</pubDate>
<description>Appendix 4E</description>
</item>
<item>
<title>Strategic partnership with Know Your Lemons Foundation</title>
<link>https://6ix.com/company/rhythm-biosciences-ltd/news/strategic-partnership-with-know-your-lemons-foundation</link>
<guid isPermaLink="true">https://6ix.com/company/rhythm-biosciences-ltd/news/strategic-partnership-with-know-your-lemons-foundation</guid>
<pubDate>Thu, 28 Aug 2025 03:51:27 GMT</pubDate>
<description>Strategic partnership with Know Your Lemons Foundation</description>
</item>
<item>
<title>ColoSTAT Kit Validation Completion and NATA Submission</title>
<link>https://6ix.com/company/rhythm-biosciences-ltd/news/colostat-kit-validation-completion-and-nata-submission</link>
<guid isPermaLink="true">https://6ix.com/company/rhythm-biosciences-ltd/news/colostat-kit-validation-completion-and-nata-submission</guid>
<pubDate>Tue, 26 Aug 2025 03:43:48 GMT</pubDate>
<description>ColoSTAT Kit Validation Completion and NATA Submission</description>
</item>
<item>
<title>Placement Prospectus</title>
<link>https://6ix.com/company/rhythm-biosciences-ltd/news/placement-prospectus-2</link>
<guid isPermaLink="true">https://6ix.com/company/rhythm-biosciences-ltd/news/placement-prospectus-2</guid>
<pubDate>Mon, 18 Aug 2025 07:05:09 GMT</pubDate>
<description>Placement Prospectus</description>
</item>
<item>
<title>Share Placement to Raise Up To $3.75 million</title>
<link>https://6ix.com/company/rhythm-biosciences-ltd/news/share-placement-to-raise-up-to-dollar375-million</link>
<guid isPermaLink="true">https://6ix.com/company/rhythm-biosciences-ltd/news/share-placement-to-raise-up-to-dollar375-million</guid>
<pubDate>Mon, 18 Aug 2025 03:53:21 GMT</pubDate>
<description>Share Placement to Raise Up To $3.75 million</description>
</item>
</channel>
</rss>